Top of the Morning : Wall Street Tanks | Gift Nifty Glitters, But Caution Reigns | Kohli’s New Innings

This is Nelson John, and I'll bring you the top business and tech stories, let's get started. Markets Whiplash on Tariff ConfusionWall Street’s Wednesday rally didn’t last long. By Thursday, markets tanked after a White House clarification revealed tariffs on Chinese imports would rise to 145%, not the expected 125%. The S&P 500 fell 3.46%, the Dow lost 1,014 points, and the Nasdaq tumbled 4.31%, led by a tech sell-off—Tesla dropped 8%, Meta and Nvidia 7% each, and Apple over 4%. A tame inflation report failed to calm nerves as fears of a prolonged trade war resurfaced. At one point, the Dow was down more than 2,100 points. The message? Markets are fragile—and volatility is here to stay.India Preps for a Market Pop—But Risk LurksWith Indian markets closed for Mahavir Jayanti, Gift Nifty hinted at a 600–700 point gap-up on reopening. That’s thanks to President Trump pausing tariffs on most U.S. trade partners—except China. But experts advise caution. “Don’t let the pop cloud your judgment,” warned Ambareesh Baliga. Nilesh Shah of Kotak AMC called for disciplined asset allocation, while Shankar Sharma flagged policy flip-flopping. FIIs have hedged positions, but retail traders shorting calls might feel the burn. RBI’s rate cut also drew a lukewarm response. The bottom line? The rally might be real, but the risk is too.Indian Pharma Feels the Heat Despite 90-Day Tariff PausePharma stocks aren’t celebrating the temporary tariff breather. A White House note on April 2 specifically targeted pharmaceuticals—triggering a 10% fall in Biocon and Aurobindo, and a 5% dip in Dr Reddy’s. Sun Pharma has been more resilient, down just 3.6%. India supplies half of the U.S.’s generics, making it extremely vulnerable. Experts warn that if companies can’t absorb the costs, they may pull out—leading to shortages similar to the COVID era. Nomura notes that making generics in the U.S. is up to 8x costlier. So while the pause buys time, uncertainty lingers.Siemens CEO and Family Killed in Helicopter CrashA family vacation turned tragic on April 10 as Siemens Mobility Southwest Europe CEO Agustin Escobar, his wife, and three young children died in a helicopter crash over the Hudson River. The Bell 206 went down upside-down at 3:15 pm local time. Just hours before, they’d posed smiling in front of the chopper. Witnesses saw the tail and rotor fall mid-air, sending the aircraft into a deadly spin. “They were dead as soon as whatever happened happened,” said aviation expert Justin Green. The FAA and NTSB are probing the crash. Escobar, a 25-year Siemens veteran, was also VP of the German Chamber of Commerce in Spain. His death leaves a void in the global infrastructure and energy sectors.Kohli Ditches Puma, Bets Big on AgilitasVirat Kohli is stepping off the pitch and into the boardroom. As his ₹110 crore contract with Puma ends, Kohli is joining Agilitas—a homegrown sportswear brand started by ex-Puma India MD Abhishek Ganguly—as an investor and brand ambassador. Agilitas will take over manufacturing and global scaling of Kohli’s lifestyle label One8. The goal? Build a world-class Indian challenger to global giants. Puma acknowledged the split and wished him well. Over the past year, Kohli’s been seen in neutral gear—signaling a transition. With ₹530 crore in funding and brands like Lotto and Mochiko under its belt, Agilitas is on the rise. For Kohli, this isn’t just brand building—it’s business building.